Publication: A Rare Variant of Glioblastoma Is Gliosarcoma: 11-Case Clinical Trial
| dc.authorscopusid | 58971785200 | |
| dc.authorscopusid | 58972202500 | |
| dc.authorscopusid | 58971571000 | |
| dc.authorscopusid | 36463197200 | |
| dc.authorscopusid | 55936052000 | |
| dc.contributor.author | Engin, R. | |
| dc.contributor.author | Tomakin, F. | |
| dc.contributor.author | Gökalp, G. | |
| dc.contributor.author | Aras, M. | |
| dc.contributor.author | Çokluk, C. | |
| dc.date.accessioned | 2025-12-11T00:33:24Z | |
| dc.date.issued | 2024 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Engin] Recai, Department of Neurosurgery, Kahramanmaraş Necip Fazıl City Hospital, Kahramanmaras, Kahramanmaraş, Turkey; [Tomakin] Fatih, Department of Neurosurgery, Unye State Hospital, Ordu, Ordu, Turkey; [Gökalp] Gürkan, Department of Neurosurgery, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Aras] Mustafa, Department of Neurosurgery, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Çokluk] Cengiz, Department of Neurosurgery, Ondokuz Mayis University, Medical School, Samsun, Turkey | en_US |
| dc.description.abstract | Gliosarcoma is a rare subtype of glioblastoma, IDH wild type. Its characteristic features are a biphasic configuration with mixed glial and mesenchymal components. Here in, we present a rare case of Gliosarcoma that has been operated in our clinic in the last 10 years. Patients with gliosarcoma pathology results were collected from the ones operated in our faculty within 10 years. Patients from all age groups were included in the study. 1 of 11 gliosarcoma cases was described in detail. Seven of the cases were male, while 4 were female. Regarding tumor location, six 6 were located in the right, while 5 were in the left hemisphere. The average survival time of all 11 patients was 11 months. In 6 cases, the initial pathologic diagnosis was gliosarcoma, while in 5 cases, it was glioblastoma, and in the 2nd case, the pathology result was gliosarcoma. Gliosarcomas have a worse prognosis in terms of survival. Clinically, it is not possible to distinguish between glioblastomas and gliosarcomas. Treatment proceeds in the same way. © 2024 Ondokuz Mayis Universitesi. All rights reserved. | en_US |
| dc.identifier.doi | 10.52142/omujecm.41.1.25 | |
| dc.identifier.endpage | 154 | en_US |
| dc.identifier.issn | 1309-4483 | |
| dc.identifier.issn | 1309-5129 | |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.scopus | 2-s2.0-85189521271 | |
| dc.identifier.scopusquality | Q4 | |
| dc.identifier.startpage | 152 | en_US |
| dc.identifier.uri | https://doi.org/10.52142/omujecm.41.1.25 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/37367 | |
| dc.identifier.volume | 41 | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Ondokuz Mayis Üniversitesi | en_US |
| dc.relation.ispartof | Journal of Experimental and Clinical Medicine (Turkey) | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Brain Tumor | en_US |
| dc.subject | Glioblastoma | en_US |
| dc.subject | Gliosarcoma | en_US |
| dc.subject | Isocitrate Dehydrogenase | en_US |
| dc.title | A Rare Variant of Glioblastoma Is Gliosarcoma: 11-Case Clinical Trial | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |
